ABSTRACT
Despite growing evidence on the role of private health providers, the global public health response to date has primarily focused on the provision of public sector health services for women and children in low and middle income countries (LMIC). Limitations of this approach are well documented and include: shortage of human resources, inefficient institutional frameworks and inadequate quality especially in rural areas. In order to achieve Universal Health Coverage, it is important to strengthen both the public and private sector. The objective was to determine effective strategies for engagement with private health providers for maternal and child health in LMIC.
A scoping review of both published and grey literature from 2000 – 2022 was undertaken, using including all types of papers reporting on: either population level data on the extent of utilization of the private sector for maternal and child health services in more than one country; or interventions for service provision in the private sector using population level results in one or more country; Or both of the above. Aggregate results were extracted, and content analysis was used to identify engagement strategies/themes.
The results confirm that the private sector is the dominant provider of outpatient care for women and children in LMIC, and a significant provider of reproductive and maternal health services including for inpatient care. Effective strategies and recommendations for engagement with private health providers are presented across challenges of private health provider engagement.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by UNICEF and UNDP
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos